Rubric Capital Management (New York)’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Rubric Capital Management (New York)’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-877,161	Closed	-$4.4M	–	106
2022 Q4	$4.4M	Hold	877,161	–	–	0.19%	74
2022 Q3	$11.5M	Buy	877,161 +79,573	+10%	+$1.21M	0.58%	43
2022 Q2	$10.2M	Buy	+797,588	New	+$11M	0.54%	43

Other funds holding NGM

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return